Company Encyclopedia
View More
name
First Trust Nasdaq Food & Pharma
FTXH.US
News
View More

With Netflix's 10-for-1 Stock Split Complete, Here Are 3 Growth Stocks to Buy in December That Could Issue Stock Splits in 2026

Netflix completed a 10-for-1 stock split, making shares more accessible at around $100 each. This move could increase Netflix's chances of joining the Dow Jones Industrial Average. Meta Platforms, ASML, and Eli Lilly are predicted to issue stock splits in 2026, making them attractive growth stocks to buy in December. Meta could replace Verizon in the Dow, ASML is poised for technological advancements in AI chips, and Eli Lilly's success is driven by its GLP-1 medications.

Motley Fool·
US
NFLX
-0.71%
US
ASML
-2.70%
US
META
+3.43%
Motley Fool·
US
NFLX
-0.71%
US
ASML
-2.70%
US
META
+3.43%

Health Care Down Sharply on Rotation to Rate-Sensitive Sectors -- Health Care Roundup

Health-care stocks fell sharply as traders shifted to rate-sensitive sectors. Halozyme secured a preliminary injunction against Merck & Co. in a patent dispute over Keytruda in Germany. The Trump administration's biomedical innovation goals face challenges within the FDA, amid infighting and staff turnover influenced by Robert F. Kennedy Jr.'s policy changes.

marketscreener·
US
MRK
-1.35%
US
HALO
-2.64%
marketscreener·
US
MRK
-1.35%
US
HALO
-2.64%

Bristol Myers Squibb Co. Stock Outperforms Competitors On Strong Trading Day

Bristol Myers Squibb Co. (BMY) stock rose 1.94% to $51.95, outperforming competitors in a mixed market session. The S&P 500 increased by 0.11%, while the Dow Jones fell by 0.07%. This marks the second consecutive day of gains for BMY, which remains 17.97% below its 52-week high. Trading volume was 19.8 million, surpassing the 50-day average of 16.9 million.

Dow Jones·
US
BMY
+1.94%
Dow Jones·
US
BMY
+1.94%

Merck Raises $8 Billion in Multi-Tranche Notes Offering

Merck & Co., Inc. has raised $8 billion through a multi-tranche notes offering, including various debt instruments with maturities ranging from 2029 to 2065. The offering closed on December 4, 2025, under the company's shelf registration statement filed with the SEC. This capital raising effort involves several series of notes with varying interest rates and maturities.

Reuters·
US
MRK
-1.35%
Reuters·
US
MRK
-1.35%

Amgen Inc. Stock Underperforms Thursday When Compared To Competitors

Amgen Inc. shares fell 1.52% to $340.16 on Thursday, underperforming compared to competitors. The S&P 500 Index rose 0.11%, while the Dow Jones Industrial Average fell 0.07%. Amgen's stock ended a two-day winning streak and closed 1.80% below its 52-week high. Competitors' performances varied: Johnson & Johnson fell 1.39%, Pfizer rose 0.51%, and AbbVie fell 0.66%. Trading volume was 3.4 million, above the 50-day average of 2.5 million.

Dow Jones·
US
JNJ
-1.39%
US
AMGN
-1.52%
US
ABBV
-0.66%
Dow Jones·
US
JNJ
-1.39%
US
AMGN
-1.52%
US
ABBV
-0.66%
© 2025 Longbridge｜Disclaimer